Steward Partners Investment Advisory, LLC Abiomed Inc Transaction History

Steward Partners Investment Advisory, LLC

$10.6 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$242.49 - $301.46 $4,364 - $5,426	18 Added 1.4%	1,306 $321,000
Q2 2022 Aug 04, 2022	BUY	$224.73 - $338.64 $224,280 - $337,962	998 Added 344.14%	1,288 $319,000
Q1 2022 May 02, 2022	SELL	$277.25 - $366.29 $88,997 - $117,579	-321 Reduced 52.54%	290 $96,000
Q4 2021 Feb 08, 2022	SELL	$300.63 - $371.35 $17,135 - $21,166	-57 Reduced 8.53%	611 $219,000
Q3 2021 Nov 12, 2021	BUY	$310.19 - $376.2 $7,754 - $9,405	25 Added 3.89%	668 $217,000
Q2 2021 Aug 13, 2021	SELL	$262.71 - $351.17 $61,999 - $82,876	-236 Reduced 26.85%	643 $201,000
Q1 2021 May 14, 2021	BUY	$285.92 - $355.13 $80,343 - $99,791	281 Added 46.99%	879 $280,000
Q4 2020 Feb 11, 2021	SELL	$251.88 - $324.2 $25,188 - $32,420	-100 Reduced 14.33%	598 $194,000
Q3 2020 Oct 30, 2020	BUY	$255.22 - $317.0 $26,798 - $33,285	105 Added 17.71%	698 $193,000
Q2 2020 Aug 06, 2020	SELL	$141.4 - $257.09 $15,554 - $28,279	-110 Reduced 15.65%	593 $143,000
Q1 2020 Apr 29, 2020	SELL	$130.51 - $196.01 $652 - $980	-5 Reduced 0.71%	703 $102,000
Q3 2019 Oct 30, 2019	BUY	$175.89 - $279.23 $1,583 - $2,513	9 Added 1.29%	708 $125,000
Q2 2019 Jul 25, 2019	BUY	$250.96 - $284.94 $175,421 - $199,173	699 New	699 $182,000
Q4 2018 Jan 15, 2019	SELL	$281.08 - $444.25 $19,394 - $30,653	-69 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$354.53 - $449.75 $8,863 - $11,243	25 Added 56.82%	69 $31,000
Q2 2018 Jul 20, 2018	BUY	$278.07 - $446.21 $6,395 - $10,262	23 Added 109.52%	44 $18,000
Q1 2018 Apr 20, 2018	BUY	$192.49 - $295.85 $4,042 - $6,212	21 New	21 $6,000
Q4 2017 Jan 19, 2018	SELL	$168.78 - $199.74 $13,671 - $16,178	-81 Closed	0 $0
Q4 2016 Nov 22, 2017	BUY	N/A	81	81 $9,000

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account